Natalia L Klyachko Selected Research

Natalia L Klyachko Research Topics

Disease

7	Neoplasms (Cancer) 12/2023 - 07/2015
6	Parkinson Disease (Parkinson's Disease) 11/2021 - 04/2010
4	Adenocarcinoma 12/2023 - 07/2015
4	Inflammation (Inflammations) 04/2021 - 01/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 01/2012
2	Bacterial Infections (Bacterial Infection) 12/2023 - 12/2014
2	Uveitis 04/2021 - 01/2015
2	Edema (Dropsy) 04/2021 - 01/2015
2	Hyperemia 04/2021 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2021
2	Hyperthermia 01/2018 - 12/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2023
1	Experimental Melanoma 12/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Blindness (Hysterical Blindness) 04/2021
1	Eye Diseases (Eye Disease) 04/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Rupture 09/2019
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 09/2017
1	Cataract (Cataracts) 01/2015
1	Brain Injuries (Brain Injury) 09/2012
1	Neuroinflammatory Diseases 06/2012
1	Disease Progression 04/2010

Drug/Important Bio-Agent (IBA)

7	EnzymesIBA 04/2021 - 01/2011
6	AntioxidantsIBA 04/2021 - 01/2012
6	CatalaseIBA 09/2017 - 01/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 04/2016
2	CopperIBA 12/2023 - 12/2023
2	ProdrugsIBA 01/2022 - 07/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	FibrinIBA 04/2021 - 01/2015
2	Superoxide Dismutase-1IBA 04/2021 - 01/2015
2	GlycoconjugatesIBA 01/2021 - 01/2021
2	AcetylgalactosamineIBA 01/2021 - 01/2021
2	Cytostatic AgentsIBA 01/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 01/2021 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2020
1	IonsIBA 12/2023
1	Liposomes (Liposome)IBA 12/2023
1	Amyloid (Amyloid Fibrils)IBA 10/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Coenzyme A (CoA)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	PlatinumIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	CarbonIBA 01/2022
1	betulinIBA 01/2021
1	taxaneIBA 01/2021
1	LectinsIBA 01/2020
1	LigandsIBA 01/2020
1	Asialoglycoprotein ReceptorIBA 01/2020
1	LipidsIBA 09/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Sepharose (Agarose)IBA 01/2018
1	Contrast MediaIBA 01/2018
1	sigma Receptors (sigma Receptor)IBA 01/2018
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2018
1	AlginatesIBA 07/2015
1	Capsules (Microcapsules)IBA 07/2015
1	Methotrexate (Mexate)FDA LinkGeneric 07/2015
1	oligochitosanIBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2012

Therapy/Procedure

8	Therapeutics 12/2023 - 04/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Lasers (Laser) 12/2021
1	Aftercare (After-Treatment) 12/2021